Regions Financial Corp’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,216
| Closed | -$327K | – | 865 |
|
|
2026
Q1 | $327K | Buy |
5,216
+53
| +1% | +$4.24K | ﹤0.01% | 727 |
|
|
2025
Q4 | $492K | Buy |
5,163
+2,217
| +75% | +$217K | ﹤0.01% | 610 |
|
|
2025
Q3 | $288K | Buy |
2,946
+514
| +21% | +$53.2K | ﹤0.01% | 732 |
|
|
2025
Q2 | $261K | Sell |
2,432
-104
| -4% | -$10.5K | ﹤0.01% | 753 |
|
|
2025
Q1 | $256K | Buy |
2,536
+148
| +6% | +$14.9K | ﹤0.01% | 736 |
|
|
2024
Q4 | $213K | Buy |
+2,388
| New | +$210K | ﹤0.01% | 780 |
|
|
2024
Q3 | – | Sell |
-2,632
| Closed | -$203K | – | 835 |
|
|
2024
Q2 | $203K | Buy |
+2,632
| New | +$193K | ﹤0.01% | 794 |
|
|
2021
Q2 | – | Sell |
-5,279
| Closed | -$204K | – | 911 |
|
|
2021
Q1 | $204K | Sell |
5,279
-1,006
| -16% | -$38.1K | ﹤0.01% | 813 |
|
|
2020
Q4 | $226K | Sell |
6,285
-4,012
| -39% | -$145K | ﹤0.01% | 762 |
|
|
2020
Q3 | $393K | Sell |
10,297
-239
| -2% | -$9.21K | ﹤0.01% | 576 |
|
|
2020
Q2 | $370K | Hold |
10,536
| – | – | ﹤0.01% | 579 |
|
|
2020
Q1 | $344K | Buy |
10,536
+1,070
| +11% | +$41.8K | ﹤0.01% | 559 |
|
|
2019
Q4 | $428K | Buy |
9,466
+908
| +11% | +$38K | ﹤0.01% | 573 |
|
|
2019
Q3 | $348K | Hold |
8,558
| – | – | ﹤0.01% | 600 |
|
|
2019
Q2 | $368K | Sell |
8,558
-700
| -8% | -$26.9K | ﹤0.01% | 593 |
|
|
2019
Q1 | $356K | Sell |
9,258
-345
| -4% | -$13.2K | ﹤0.01% | 611 |
|
|
2018
Q4 | $340K | Buy |
9,603
+2,666
| +38% | +$96.7K | ﹤0.01% | 600 |
|
|
2018
Q3 | $267K | Hold |
6,937
| – | – | ﹤0.01% | 751 |
|
|
2018
Q2 | $227K | Sell |
6,937
-339
| -5% | -$10.2K | ﹤0.01% | 780 |
|
|
2018
Q1 | $198K | Sell |
7,276
-2,229
| -23% | -$60.6K | ﹤0.01% | 831 |
|
|
2017
Q4 | $235K | Sell |
9,505
-39,911
| -81% | -$1.1M | ﹤0.01% | 800 |
|
|
2017
Q3 | $1.44M | Buy |
49,416
+9,253
| +23% | +$256K | 0.02% | 361 |
|
|
2017
Q2 | $1.11M | Sell |
40,163
-2,746
| -6% | -$72.9K | 0.01% | 416 |
|
|
2017
Q1 | $1.07M | Sell |
42,909
-14,926
| -26% | -$363K | 0.01% | 488 |
|
|
2016
Q4 | $1.25M | Buy |
57,835
+3,732
| +7% | +$81.4K | 0.02% | 441 |
|
|
2016
Q3 | $1.29M | Sell |
54,103
-1,899
| -3% | -$45.3K | 0.02% | 434 |
|
|
2016
Q2 | $1.31M | Buy |
+56,002
| New | +$1.21M | 0.02% | 417 |
|
|
2014
Q4 | – | Sell |
-12,647
| Closed | -$149K | – | 948 |
|
|
2014
Q3 | $149K | Sell |
12,647
-3,207
| -20% | -$40.4K | ﹤0.01% | 1082 |
|
|
2014
Q2 | $202K | Sell |
15,854
-268
| -2% | -$3.48K | ﹤0.01% | 1074 |
|
|
2014
Q1 | $218K | Buy |
16,122
+3,275
| +25% | +$43K | ﹤0.01% | 1037 |
|
|
2013
Q4 | $154K | Sell |
12,847
-2,165
| -14% | -$25.6K | ﹤0.01% | 1084 |
|
|
2013
Q3 | $177K | Buy |
15,012
+4,194
| +39% | +$45.4K | ﹤0.01% | 1032 |
|
|
2013
Q2 | $100K | Buy |
+10,818
| New | +$91.8K | ﹤0.01% | 1036 |
|
Other funds holding BSX
Regions Financial Corp's BSX Position: Q2 2026 in Review
Regions Financial Corp sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,216 shares — an estimated $327K sold.
Regions Financial Corp first reported a position in BSX in Q2 2013 and held it in 33 quarters. The position peaked at $1.44M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Regions Financial Corp reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Regions Financial Corp sold 5,216 Boston Scientific shares in Q2 2026, an estimated $327K.
- Regions Financial Corp first reported a position in Boston Scientific in Q2 2013 and held it in 33 quarters.
- Regions Financial Corp's Boston Scientific position peaked at $1.44M in Q3 2017.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.